Samrat Pharmachem Ltd

₹ 482 -1.89%

30 May - close price

About

Samrat Pharmachem Ltd is primarily engaged in manufacturing of various types of Iodine compounds.^[1]

Key Points

Product Offerings
The company's product offerings include various types of iodine compounds^[1] which find applications in Pharmaceutical, FMCG, Animal Feed, Chemicals and Agrochemical industries.^[2]

Website BSE

Market Cap ₹ 149 Cr.
Current Price ₹ 482
High / Low ₹ 1,250 / 332
Stock P/E 8.96
Book Value ₹ 204
Dividend Yield 0.21 %
ROCE 34.9 %
ROE 30.2 %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Company is expected to give good quarter
Company has delivered good profit growth of 38.9% CAGR over last 5 years
Company has a good return on equity (ROE) track record: 3 Years ROE 32.6%

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Figures in Rs. Crores

	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023
	30.28	35.27	41.50	54.85	47.41	47.24	59.08	55.34	60.10	86.51	71.12	83.85	69.18
	29.35	33.65	38.84	52.40	45.46	45.82	54.92	46.73	50.03	73.63	62.86	80.57	69.67
Operating Profit	0.93	1.62	2.66	2.45	1.95	1.42	4.16	8.61	10.07	12.88	8.26	3.28	-0.49
OPM %	3.07%	4.59%	6.41%	4.47%	4.11%	3.01%	7.04%	15.56%	16.76%	14.89%	11.61%	3.91%	-0.71%
	0.07	0.02	0.02	0.09	0.30	0.15	0.07	0.23	0.16	0.03	0.16	0.28	0.03
Interest	0.33	0.46	0.28	0.36	0.17	0.17	0.21	0.13	0.17	0.23	0.24	0.62	0.17
Depreciation	0.11	0.11	0.12	0.13	0.13	0.14	0.15	0.15	0.15	0.16	0.16	0.16	0.16
Profit before tax	0.56	1.07	2.28	2.05	1.95	1.26	3.87	8.56	9.91	12.52	8.02	2.78	-0.79
Tax %	30.36%	25.23%	37.28%	25.37%	19.49%	24.60%	27.91%	24.77%	29.47%	25.24%	26.31%	24.46%	6.33%
Net Profit	0.39	0.80	1.44	1.54	1.56	0.95	2.79	6.45	7.00	9.37	5.91	2.10	-0.74
EPS in Rs	1.26	2.59	4.66	4.98	5.05	3.07	9.03	20.88	22.66	30.33	19.13	6.80	-2.40
Raw PDF

Profit & Loss

Figures in Rs. Crores

	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
	70	72	65	47	63	73	93	111	137	179	222	311
	63	71	64	46	62	69	87	108	131	170	197	287
Operating Profit	6	1	1	1	1	4	6	3	7	9	24	24
OPM %	9%	2%	1%	2%	2%	5%	6%	3%	5%	5%	11%	8%
	0	1	1	0	0	0	0	0	1	0	1	0
Interest	1	1	1	1	1	1	1	1	1	1	1	1
Depreciation	0	0	0	0	0	0	0	0	0	0	1	1
Profit before tax	6	1	0	0	0	3	5	2	6	7	24	23
Tax %	35%	31%	41%	35%	33%	37%	35%	29%	27%	27%	27%	26%
Net Profit	4	0	0	0	0	2	3	2	4	5	17	17
EPS in Rs	12.23	1.29	0.78	1.04	0.97	5.66	10.42	4.98	13.72	17.25	55.60	53.82
Dividend Payout %	-0%	-0%	-0%	-0%	-0%	-0%	-0%	-0%	-0%	-0%	2%	2%

Compounded Sales Growth
10 Years:	16%
5 Years:	27%
3 Years:	31%
TTM:	40%

Compounded Profit Growth
10 Years:	45%
5 Years:	39%
3 Years:	58%
TTM:	-3%

Stock Price CAGR
10 Years:	35%
5 Years:	29%
3 Years:	88%
1 Year:	9%

Return on Equity
10 Years:	22%
5 Years:	28%
3 Years:	33%
Last Year:	30%

Balance Sheet

Figures in Rs. Crores

	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
	3	3	3	3	3	3	3	3	3	3	3	3
Reserves	9	10	10	10	11	12	15	17	21	27	44	60
	3	4	3	3	6	7	9	7	9	9	8	19
	16	17	15	10	17	14	13	14	25	19	30	34
Total Liabilities	32	34	31	26	36	36	41	40	58	57	85	116
	4	4	8	7	7	7	7	7	7	9	10	11
CWIP	3	4	-0	-0	-0	0	-0	-0	1	-0	-0	-0
Investments	-0	-0	-0	-0	2	-0	-0	-0	-0	-0	0	2
	25	27	24	19	27	29	34	33	50	48	75	104
Total Assets	32	34	31	26	36	36	41	40	58	57	85	116

Cash Flows

Figures in Rs. Crores

	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022
	4	-2	4	-1	-0	-3	0	2	-1	5	18
	-4	-1	-0	0	-2	1	-2	2	-2	-3	-1
	2	1	-1	0	2	1	2	-4	2	-2	-2
Net Cash Flow	2	-2	2	-0	-0	-1	-1	1	-1	-0	14

Ratios

Figures in Rs. Crores

	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Debtor Days	55	60	63	74	93	59	86	69	74	67	72	60
Inventory Days	46	54	45	38	37	41	31	28	55	25	24	43
Days Payable	86	89	87	76	104	43	46	45	67	39	45	42
Cash Conversion Cycle	15	25	21	36	26	58	70	52	61	53	51	61
Working Capital Days	27	37	25	39	35	61	65	56	63	54	44	62
ROCE %	49%	9%	7%	7%	5%	16%	23%	12%	22%	24%	52%	35%

Shareholding Pattern

Numbers in percentages

Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023
49.13	49.13	49.13	49.30	49.30	49.30	49.65	49.65	49.65	49.54	48.64	48.64
3.24	0.00	3.24	3.24	3.24	3.24	0.00	0.00	3.24	3.24	3.24	3.24
0.00	3.24	0.00	0.00	0.00	0.00	3.24	3.24	0.00	0.00	0.00	0.00
47.63	47.63	47.63	47.46	47.46	47.46	47.12	47.12	47.12	47.23	48.13	48.13

Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
47.87	48.76	49.02	49.13	49.30	49.65	48.64
0.00	3.24	0.00	0.00	3.24	0.00	3.24
3.24	0.00	3.24	3.24	0.00	3.24	0.00
48.89	48.01	47.74	47.63	47.46	47.12	48.13

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Samrat Pharmachem Ltd

Samrat Pharmachem Ltd

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flows

Ratios

Shareholding Pattern

Documents

Announcements

Annual reports

Credit ratings